Strategies to manage hepatitis C virus infection disease burden-Volume 4

Unknown

doi:https://doi.org/10.1111/jvh.12759

Strategies to manage hepatitis C virus infection disease burden-Volume 4

Unknown

Global Health (AMC)

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

Abstract

The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets-"WHO Targets" (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) were considered. Scaling up treatment and diagnosis rates over time would be required to achieve these targets in all but one country, even with the introduction of high SVR therapies. The scenarios developed to achieve the WHO Targets in all countries studied assumed the implementation of national policies to prevent new infections and to diagnose current infections through screening.

Original language	English
Pages (from-to)	44-63
Number of pages	20
Journal	Journal of viral hepatitis
Volume	24 Suppl 2
DOIs	https://doi.org/10.1111/jvh.12759
Publication status	Published - 2017

Keywords

Antiviral Agents/therapeutic use
Disease Management
Global Health
Health Policy
Hepatitis C, Chronic/diagnosis
Humans
Incidence
Prevalence
Viremia/diagnosis

Access to Document

https://doi.org/10.1111/jvh.12759

Cite this

@article{2f3689818fb24277928179d9b3086041,

title = "Strategies to manage hepatitis C virus infection disease burden-Volume 4",

abstract = "The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets-{"}WHO Targets{"} (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) were considered. Scaling up treatment and diagnosis rates over time would be required to achieve these targets in all but one country, even with the introduction of high SVR therapies. The scenarios developed to achieve the WHO Targets in all countries studied assumed the implementation of national policies to prevent new infections and to diagnose current infections through screening.",

keywords = "Antiviral Agents/therapeutic use, Disease Management, Global Health, Health Policy, Hepatitis C, Chronic/diagnosis, Humans, Incidence, Prevalence, Viremia/diagnosis",

author = "Unknown and Chen, {D S} and W Hamoudi and B Mustapha and J Layden and A Nersesov and T Reic and V Garcia and C Rios and L Mateva and O Njoya and Al-Busafi, {S A} and Abdelmageed, {M K} and M Abdulla and D Adda and O Akin and {Al Baqali}, A and {Al Dweik}, N and {Al Ejji}, K and {Al Ghazzawi}, I and {Al Kaabi}, S and {Al Naamani}, K and {Al Qamish}, J and {Al Sadadi}, M and {Al Salman}, J and M AlBadri and Al-Romaihi, {H E} and W Ampofo and K Antonov and C Anyaike and F Arome and A Bane and S Blach and Borodo, {M M} and Brandon, {S M} and B Bright and Butt, {M T} and I Cardenas and Chan, {H L Y} and Chen, {C J} and Chen, {P J} and Chien, {R N} and Chuang, {W L} and D Cuellar and M Derbala and Elbardiny, {A A} and E Farag and P Ondoa and {Rinke de Wit}, T and Su, {T H} and Tan, {S S}",

year = "2017",

doi = "https://doi.org/10.1111/jvh.12759",

language = "English",

volume = "24 Suppl 2",

pages = "44--63",

journal = "Journal of viral hepatitis",

issn = "1352-0504",

publisher = "Wiley",

}

TY - JOUR

T1 - Strategies to manage hepatitis C virus infection disease burden-Volume 4

AU - Unknown

AU - Chen, D S

AU - Hamoudi, W

AU - Mustapha, B

AU - Layden, J

AU - Nersesov, A

AU - Reic, T

AU - Garcia, V

AU - Rios, C

AU - Mateva, L

AU - Njoya, O

AU - Al-Busafi, S A

AU - Abdelmageed, M K

AU - Abdulla, M

AU - Adda, D

AU - Akin, O

AU - Al Baqali, A

AU - Al Dweik, N

AU - Al Ejji, K

AU - Al Ghazzawi, I

AU - Al Kaabi, S

AU - Al Naamani, K

AU - Al Qamish, J

AU - Al Sadadi, M

AU - Al Salman, J

AU - AlBadri, M

AU - Al-Romaihi, H E

AU - Ampofo, W

AU - Antonov, K

AU - Anyaike, C

AU - Arome, F

AU - Bane, A

AU - Blach, S

AU - Borodo, M M

AU - Brandon, S M

AU - Bright, B

AU - Butt, M T

AU - Cardenas, I

AU - Chan, H L Y

AU - Chen, C J

AU - Chen, P J

AU - Chien, R N

AU - Chuang, W L

AU - Cuellar, D

AU - Derbala, M

AU - Elbardiny, A A

AU - Farag, E

AU - Ondoa, P

AU - Rinke de Wit, T

AU - Su, T H

AU - Tan, S S

PY - 2017

Y1 - 2017

N2 - The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets-"WHO Targets" (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) were considered. Scaling up treatment and diagnosis rates over time would be required to achieve these targets in all but one country, even with the introduction of high SVR therapies. The scenarios developed to achieve the WHO Targets in all countries studied assumed the implementation of national policies to prevent new infections and to diagnose current infections through screening.

AB - The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets-"WHO Targets" (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) were considered. Scaling up treatment and diagnosis rates over time would be required to achieve these targets in all but one country, even with the introduction of high SVR therapies. The scenarios developed to achieve the WHO Targets in all countries studied assumed the implementation of national policies to prevent new infections and to diagnose current infections through screening.

KW - Antiviral Agents/therapeutic use

KW - Disease Management

KW - Global Health

KW - Health Policy

KW - Hepatitis C, Chronic/diagnosis

KW - Humans

KW - Incidence

KW - Prevalence

KW - Viremia/diagnosis

U2 - https://doi.org/10.1111/jvh.12759

DO - https://doi.org/10.1111/jvh.12759

M3 - Article

C2 - 29105286

SN - 1352-0504

VL - 24 Suppl 2

SP - 44

EP - 63

JO - Journal of viral hepatitis

JF - Journal of viral hepatitis

ER -